Ernexa Therapeutics (ERNAW) Change in Receivables (2010 - 2021)
Ernexa Therapeutics' (ERNAW) quarterly Change in Receivables came in at $663680.0 in Q4 2021, up 14281.2% on a QoQ basis from -$4680.0 in Q1 2021.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Change in Receivables (2010 - 2021) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 11 years of Change in Receivables data on file, last reported at $663680.0 in Q4 2021.
- Quarterly Change in Receivables changed N/A year-over-year to $663680.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $659000.0 (changed N/A YoY) and the FY2021 annual result came in at $659000.0, changed N/A from the prior year.
- Change in Receivables rose to $663680.0 in Q4 2021, from -$4680.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $863000.0 in Q1 2017 to a low of -$990000.0 in Q2 2017.
- A 4-year average of $90857.1 and a median of $53660.0 in 2017 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 784.92% in 2017, down 673.44% in 2017.
- Tracing ERNAW's Change in Receivables over 4 years: stood at $112000.0 in 2017, then tumbled by 198.21% to -$110000.0 in 2018, then surged by 527.27% to $470000.0 in 2019, then jumped by 41.21% to $663680.0 in 2021.
- The last three Change in Receivables figures came in at $663680.0 (Q4 2021), -$4680.0 (Q1 2021), and $470000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 663,680.00 |
| Mar 31, 2021 | -4,680.00 |
| Dec 31, 2019 | 470,000.00 |
| Sep 30, 2019 | 162,000.00 |
| Jun 30, 2019 | -120,000.00 |
| Mar 31, 2019 | -264,000.00 |
| Dec 31, 2018 | -110,000.00 |
| Sep 30, 2018 | 509,000.00 |
| Jun 30, 2018 | -219,000.00 |
| Mar 31, 2018 | 327,000.00 |
| Dec 31, 2017 | 112,000.00 |
| Sep 30, 2017 | -127,000.00 |
| Jun 30, 2017 | -990,000.00 |
| Mar 31, 2017 | 863,000.00 |
| Dec 31, 2016 | 37,000.00 |
| Sep 30, 2016 | 300,000.00 |
| Jun 30, 2016 | -128,000.00 |
| Mar 31, 2016 | -126,000.00 |
| Dec 31, 2015 | 360,000.00 |
| Sep 30, 2015 | 16,000.00 |